Literature DB >> 8115948

Dissecting aneurysms of the vertebrobasilar system: study of 16 cases.

E Pozzati1, A Andreoli, P Limoni, M Casmiro.   

Abstract

In the last 14 years we have encountered 16 patients with spontaneous intracranial dissections of the vertebrobasilar (VB) system (mean age was 46 years and male/female ratio was 10/6). VB dissections presented in eight cases with subarachnoid bleeding and in eight with brainstem, cerebellar, or cerebral ischemia. Three patients had multiple dissections. Ten dissections occurred in the vertebral artery (two extended to the basilar artery), three in the posterior cerebral artery (one bilateral), two in the basilar artery, and one in the posterior inferior cerebellar artery. The angiographic configuration included "string" sign, "pearl and string" sign, fusiform dilation, and double lumen. The following angiographic evolution (available in 11 cases) was that of complete healing (three cases), partial resolution (five cases), progression (one case), and unimproving (two cases). Three patients died (two due to recurrent subarachnoid hemorrhage): two patients were explored surgically (one had further intravascular therapeutic embolization), and the rest were treated conservatively. Not all dissecting aneurysms fared in the same manner, depending either on the location in the VB circulation or on the variable vascular configuration: treatment should be fitted to the timing of diagnosis.

Entities:  

Mesh:

Year:  1994        PMID: 8115948     DOI: 10.1016/0090-3019(94)90108-2

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  13 in total

1.  Treatment of vertebro-basilar dissecting aneurysms using intravascular stents.

Authors:  S Yamasaki; K Hashimoto; Y Kawano; M Yoshimura; T Yamamoto; M Hara
Journal:  Interv Neuroradiol       Date:  2006-06-15       Impact factor: 1.610

2.  Vertebral artery dissection: natural history, clinical features and therapeutic considerations.

Authors:  Kwan-Woong Park; Jong-Sun Park; Sun-Chul Hwang; Soo-Bin Im; Won-Han Shin; Bum-Tae Kim
Journal:  J Korean Neurosurg Soc       Date:  2008-09-20

3.  Treatment of a vertebral dissecting aneurysm with a balloon-expandable stent and guglielmi detachable coils.

Authors:  T Nakahara; K Kurisu; T Yano; K Sakoda
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

4.  [Endovascular occlusion of the basilar artery for the treatment of dissecting and dysplastic fusiform aneurysms].

Authors:  H Henkes; T Liebig; J Reinartz; E Miloslavski; M Kirsch; D Kühne
Journal:  Nervenarzt       Date:  2006-02       Impact factor: 1.214

Review 5.  Clinical characteristics of symptomatic vertebral artery dissection: a systematic review.

Authors:  Rebecca F Gottesman; Priti Sharma; Karen A Robinson; Martinson Arnan; Megan Tsui; Karim Ladha; David E Newman-Toker
Journal:  Neurologist       Date:  2012-09       Impact factor: 1.398

6.  Clinically occult chronic dissecting aneurysm of the superior cerebellar artery in a child.

Authors:  Ian C Duncan
Journal:  Pediatr Radiol       Date:  2005-06-02

7.  3T MRI - 3D DSA Fusion Technique on Posterior Cerebral Artery Dissecting Aneurysm: Understanding a Potential Pathophysiologic Mechanism.

Authors:  W K W Chong; S K Lee; K G Terbrugge
Journal:  Interv Neuroradiol       Date:  2006-12-13       Impact factor: 1.610

8.  Dissecting aneurysms of posterior communicating artery itself: anatomical, diagnostic, clinical, and therapeutical considerations.

Authors:  Burak Kocak; Ercan Tureci; Osman Kizilkilic; Civan Islak; Naci Kocer
Journal:  Neuroradiology       Date:  2013-06-21       Impact factor: 2.804

9.  Spontaneous intradural vertebral artery dissection: a single-center experience and review of the literature.

Authors:  Hasan Kocaeli; Chiraz Chaalala; Norberto Andaluz; Mario Zuccarello
Journal:  Skull Base       Date:  2009-05

10.  Isolated posterior cerebral artery dissection: report of three cases.

Authors:  P Sherman; M Oka; E Aldrich; L Jordan; P Gailloud
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.